Particle.news

Download on the App Store

Scientists Identify LRP8 as the Receptor Tick-Borne Encephalitis Virus Uses to Enter Human Cells

The Nature study pinpoints a neuronal entry mechanism for the virus, opening a path to entry‑blocking antivirals that still require validation in specialized models.

Overview

  • A genome-scale loss-of-function screen revealed that cells surviving TBEV exposure lacked the gene encoding the surface protein LRP8.
  • Follow-up experiments showed the virus’s envelope E protein binds LRP8, enabling attachment and entry with pronounced effects in neurons where LRP8 is highly expressed.
  • Knocking out LRP8 rendered cells resistant to infection in vitro, identifying a cellular gateway that helps explain TBEV neuroinvasion.
  • Researchers note the absence of specific treatments for TBE and propose the LRP8–E interaction as a potential target for entry-blocking drugs.
  • The authors describe this as the first identification of a single essential flavivirus receptor, a claim that they say warrants corroboration in neuronal systems and animal studies.